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Introduction
Tuberculosis killed 1.5 million people in 2014 and is the lead-
ing cause of death from an infectious disease worldwide.1 Sub-
Saharan Africa, with 28% (9.6 million) of all notified tuberculosis 
cases in 2014, endures a disproportionate burden of the disease 
relative to its population. In Gambia, the estimated incidence and 
prevalence of tuberculosis rose from 258 and 350 per 100 000 
population respectively in 1990 to 284 and 490 per 100 000 in 
2011.2 In addition, the tuberculosis case detection rate – that is, 
the ratio of the number of notified tuberculosis cases to the num-
ber of incident tuberculosis cases in a given year – remained low 
at 48% (95% confidence interval, CI: 40–58).2 It is not clear if poor 
case detection is due to inequitable access to care or inadequate 
diagnosis of tuberculosis in urban or remote parts of the country. 
Given the need for improved, evidence-based interventions 
in tuberculosis control in Gambia, it is important to establish reli-
able baseline estimates of tuberculosis prevalence against which 
future control interventions can be assessed. This study therefore 
aimed to estimate the population prevalence of active pulmonary 
tuberculosis disease in Gambia, in 2012 and to compare the case 
detection rate with global tuberculosis control targets.
Methods
Study design
We carried out a nationwide, multistage cluster survey in 
2011–2013. A sample size of 55 281 participants ≥ 15 years 
old from 80 clusters was calculated assuming a prevalence of 
292 sputum smear-positive cases per 100 000 population,3 85% 
participation target, design effect of 1.51 and application of a 
finite population correction.4 A sample size with 80 clusters was 
expected to give around 20% precision and higher than 25% preci-
sion under the most plausible scenarios, and with an intracluster 
coefficient of variation of  0.5 the calculated design effect was 1.51.
Sampling to select survey areas was multistage and without 
any stratification. First, we allocated 80 survey enumeration areas 
by regions of the country in proportion to population size based 
on the national 2003 census (Central Statistics Department, 
Government of Gambia). Following this allocation, the West 
Coast region with about 28.7% (389 274) of the population was 
to contribute 23 enumeration areas and the least populated Lower 
River region contributed four enumeration areas for 5.3% (72 184) 
of the population. This procedure was similar in outcome to the 
recommended sampling in proportion to population size.4 Then 
we randomly selected the survey enumeration areas (e.g. 23 for 
the West Coast region) up to a total of 80 for the entire country. 
Each selected survey enumeration area was paired with between 
one and two adjacent enumeration areas in whole or part until 
an adult population of 500–700 was attained.
People eligible for participation were all those aged ≥ 15 years; 
permanent residents who spent at least one night in the household 
in the preceding 4 weeks; and visitors who had arrived in the 
household 4 weeks or more before.
Study procedures
Three teams – each consisting of a research clinician who led a 
team of 7 trained fieldworkers and a radiographer – performed 
the fieldwork from December 2011 to January 2013. Data collec-
tion in each cluster was done over a seven-day period. The field 
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workers, 
in collaboration with community-
selected liaisons, enumerated the popu-
lation in each cluster 4–6 weeks before 
actual data collection. The field workers 
visited the enumerated households to 
obtain data on household composition 
and residency, and at the same time 
discussed the purpose of the survey. For 
families that were not at home, the team 
were informed at which time they could 
return to meet the household members. 
Community entry meetings with the 
local chief and other community lead-
ers were also held to provide further 
information.
The field operation sites were se-
lected based on input from community 
members to ensure that location was as 
central as possible to facilitate access by 
pedestrian travel. Project vehicles were 
available for eligible disabled partici-
pants to bring them to the site.
Screening of eligible participants 
followed the World Health Organiza-
tion (WHO) recommended algorithm 
for tuberculosis prevalence surveys.4 At 
the field operation site, participants gave 
written informed consent before they 
were interviewed for tuberculosis symp-
toms (cough, weight loss, fever, drench-
ing night sweats, chest pain, shortness 
of breath, loss of appetite and coughing 
up of blood). Then they had chest X-rays 
taken by a radiographer who used a mo-
bile direct digital radiography machine. 
Chronic cough lasting two weeks or more 
is the cardinal symptom in the national 
tuberculosis guidelines. Participants who 
screened positive for symptoms and/
or had an X-ray suggestive of tubercu-
losis were asked to submit two sputum 
specimens. All those unable to have chest 
X-rays were asked to submit two sputum 
samples whether they had symptoms or 
not. Participants submitted the sputum 
samples at the field site, with a 30–45 
minute interval. Participants who were 
unable to submit samples on-site were 
given two prelabelled containers for col-
lection early the following morning. All 
survey participants were given a token 
gift of laundry soap.
Case ascertainment
Survey clinicians were encouraged to 
over-interpret X-rays to increase the 
sensitivity of screening, as recommend-
ed.4 The radiology panel, which included 
those who trained the X-ray readers, 
reviewed all abnormal X-rays and 10% 
of normal films for quality assurance 
and definitions. The final radiological 
diagnosis was determined via consensus 
by a pulmonologist and radiologist.
Sputum specimens collected in 
the field were stored in a temperature-
monitored cold box. If the samples could 
not be transported to the laboratory 
that day, the samples were stored in a 
fridge kept at 4 C in the team’s camp. 
In general samples were transported 
every 48 hours after sputum collection 
to the main laboratory, the maximum 
delay in transportation was 72 hours. 
Sputum samples were processed at the 
Tuberculosis Diagnostic and Research 
Laboratory of the Medical Research 
Council Unit The Gambia. The labo-
ratory holds good clinical laboratory 
practice5 accreditation and subscribes 
to an external quality assessment ser-
vice.6 Sputum smears were examined 
using fluorescence microscopy. Cultures 
were performed using the BACTEC 
Mycobacterial Growth Indicator Tube 
(MGIT) system (Becton Dickinson, 
Franklin Lakes, United States of Amer-
ica). Standard laboratory procedures7 
were followed for confirmation of 
growth in liquid culture including rapid 
species identification with an immu-
nochromatographic assay (MGIT TBc 
Identification Test, Becton Dickinson, 
Franklin Lakes, USA). All acid-fast 
bacillus (AFB) isolates obtained from 
cultures were classified as either Myco-
bacterium tuberculosis or nontubercu-
lous mycobacteria.
The final survey case classifica-
tion, as defined in Box 1, was done by 
a central panel consisting of infectious 
diseases and chest physicians, epide-
miologists, laboratory experts and tu-
berculosis programme representatives.4
Data analysis
There was double entry of survey data 
in a MySQL version 5.6.19 (Oracle, Red-
wood Shores, USA) relational database. 
All data analyses were done using Stata 
version 12.1 (Stata Corp., College Sta-
tion, USA). We tested for differences in 
proportions using two-sample tests of 
equality of proportions, and conducted 
multiple imputation to correct for miss-
ing data.8,9 For prevalence estimates, we 
used three modelling approaches with 
robust standard errors, missing value 
imputation and inverse probability 
weighting applied.4,8 With multiple runs 
of chained imputation data sets, trends 
for the mean values of the four imputed 
variables (chest X-ray-positive, AFB-
positive, culture-positive and bacterio-
logically confirmed tuberculosis) were 
obtained for all iterations. We derived 
subject-level missing values from the 
relevant combinations of the imputed 
variables and stratified all prevalence 
data by sex, age group and residence 
(rural/urban). Overall prevalence for all 
forms of tuberculosis – that is, pulmo-
nary and extra-pulmonary – across all 
age groups were obtained by calculating 
pulmonary tuberculosis cases (all ages) 
as a weighted average of tuberculosis in 
survey participants and in children (ob-
tained from routine reports, Gambian 
National Tuberculosis and Leprosy Pro-
gramme). The value obtained was then 
revised upwards by the proportion of 
Box 1. Case definitions for the national tuberculosis prevalence survey, Gambia, 2012
Laboratory case definitions
Culture-confirmed tuberculosis case: isolation of Mycobacterium tuberculosis complex from a 
sputum specimen.
Sputum smear-positive tuberculosis case: acid-fast bacillus (AFB)-positive by sputum smear 
examination, i.e. at least one AFB in 100 immersion fields.
Definite survey case
Bacteriologically confirmed tuberculosis case: one positive tuberculosis culture and at least 
one of the following:
– another sample culture-positive; 
– sputum smear-positive; or
– chest X-ray abnormalities suggestive of tuberculosis by central audited reading.
Sputum smear-positive tuberculosis case: one AFB-positive sample and a culture-positive sample.
Probable smear-positive tuberculosis case
An AFB-positive sample and at least one of the following:
– AFB-positive in another sample but not culture-positive, and no isolation of nontuberculous 
mycobacteria; or
– Chest X-ray abnormal at central reading but not culture-positive, and no isolation of 
nontuberculous mycobacteria.
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all notified tuberculosis cases that were 
the extrapulmonary type. Incidence 
was calculated based on assumptions 
from a set of statistical distributions as 
described elsewhere.2
Ethics approval
The study obtained ethics approval from 
the joint ethics committee of the Gam-
bian Government and Medical Research 
Council. All tuberculosis patients iden-
tified during the survey were promptly 
referred to the nearest treatment centre 
for treatment at no cost and notified to 
the national tuberculosis programme.
Results
Participants
Enumeration yielded 100 678 people in 
13 847 households across 80 clusters, of 
whom 55 832 (55.5%) were eligible to 
participate in the survey. The enumer-
ated population was representative of 
Gambia’s population structure (2003 
national census) by age and sex (Fig. 1). 
Of the 55 832 people invited, 43 100 
(77.2%) consented to participate. As 
shown in Fig. 2, there was a significantly 
higher proportion of female (84.9%; 
25 596/30 153) than male participants 
(68.2%; 17 504/25 679; P < 0.0001). 
In addition, participation was higher 
in rural (82.3%; 25 554/31 043) than 
urban (70.8%; 17 546/24 789) clusters 
(P < 0.0001). Overall, participation was 
slightly less than the 85% target due 
to lower participation in urban areas 
and among males. The median age of 
participants was 28 years (interquartile 
range: 20–41 years).
Suspected cases
All participants were successfully 
screened for symptoms and 42 942 
(99.6%) by X-ray (Fig. 3); the majority 
of missing chest X-rays (145/158, 91.8%) 
were due to patient refusal or ill health, 
while the remaining (13/158, 8.2%) were 
due to technical problems.
Cough was reported by 4802 
(11.1%) participants. Of those par-
ticipants knowing the duration of their 
cough, 962 (2.2%) had had a cough 
lasting ≥ 2 weeks, 2979 (6.9%) had 
coughed for < 1 week and 799 (1.9%) 
had coughed for 1–2 weeks. With re-
spect to other symptoms in the guide-
lines, 6637 (15.4%) participants reported 
fever, 6551 (15.2%) chest pain, 1595 
(3.7%) night sweats, 2672 (6.2%) short-
ness of breath, 3620 (8.4%) anorexia 
and 8448 (19.6%) weight loss. Using 
other symptom categories, 1372 (3.2%) 
participants reported cough of < 2 weeks 
plus two or more of the other symptoms, 
while 1128 (2.6%) did not have a cough 
but had three or more other symptoms.
Based on field X-ray screening, 
3407 (7.9%) participants had chest ab-
normalities suggestive of tuberculosis.
A total of 5948 (13.8%) participants 
were classified as tuberculosis suspects 
and were eligible for sputum examina-
tion; 2447 were eligible by symptom 
Fig. 1. Population pyramid showing representativeness of eligible population in the 
national tuberculosis prevalence survey, Gambia, 2012
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Note: Nationwide population was 1 306 681 and eligible population was 55 832 people.
Data source: Gambia 2003 National Census, Central Statistics Department, Government of the Gambia
Fig. 2. Population pyramid showing representativeness of study population in the 
national tuberculosis prevalence survey, Gambia, 2012
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Data source: Gambia 2003 National Census, Central Statistics Department, Government of the Gambia
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screening only, 2382 by chest X-ray 
screening only and 1050 by both screen-
ing methods (Fig. 3).
Definite cases
Laboratory results were available for 5519 
participants with suspected tuberculosis. 
Overall, 77 participants with pulmonary 
tuberculosis were identified, 71 of which 
were bacteriologically confirmed. The 
expert panel categorized 28 participants’ 
diagnostic results as definite, smear-posi-
tive (smear-positive, culture-positive), 43 
as definite, bacteriologically confirmed 
(smear-negative, culture-positive) and 
six as probable, smear-positive (smear-
positive, culture-negative; Fig. 3). Of the 
samples that were both smear positive and 
culture positive; 34 samples were identi-
fied by culture as M. tuberculosis and 2 
(5.6%) as nontuberculous mycobacteria.
If sputum smear microscopy had 
been done only in symptomatic people, 
diagnosis would have been made in 52.9% 
(18/34) of prevalent smear-positive cases, 
while chest X-ray abnormalities would have 
identified 94.1% (32/34). Among all par-
ticipants with bacteriologically confirmed 
tuberculosis, symptoms alone identified 
significantly fewer cases than chest X-ray 
screening in the field, 60.6% (43/71) ver-
sus 84.1% (58/69; P < 0.01), respectively. 
In addition, 25/77 patients (32.5%) re-
ported cough for ≥ 2 weeks, 14 (18.2%) 
for < 2 weeks with two or more symptoms, 
while 5 (6.5%) did not have a cough but 
had three other symptoms. In total, 24.7% 
(19/77) of the participants were identified 
as having tuberculosis because the patient 
screened positive for additional symptoms.
Tuberculosis was identified pre-
dominantly among male participants 
(51; 66.2%). The 15–34, 35–54 and 
≥ 55 year age groups had 37.7% (29), 
39.0% (30) and 23.4% (18) of cases re-
spectively. The numbers of tuberculosis 
cases were similar in urban (39) and 
rural (38) clusters.
Most participants identified with 
tuberculosis (94.8%; 73) were not on 
treatment at the time of the survey 
and were not officially registered with 
the national tuberculosis programme. 
Thirty-eight patients had sought care 
on account of their symptoms; all 38 
had visited health facilities and the great 
majority of them (31/38) had visited a 
public health facility.
Prevalence
There were missing data for smear, 
culture and symptom identification for 
512 participants eligible for sputum 
examination; 24 of these had missing 
chest X-rays as well. Bacterial identi-
fication was a conditional imputation, 
conditioned on a positive culture. In 
addition, 134 subjects had only X-rays 
missing. In total, 646 subjects required 
imputation analysis.
For the adjusted prevalence estimates 
for smear-positive and bacteriologically 
confirmed pulmonary tuberculosis, the 
results from the three models were con-
sistent and for models 2 and 3 were quite 
similar, especially for smear-positive 
tuberculosis (Table 1). Considering the 
larger differences for bacteriologically 
confirmed tuberculosis by residence and 
sex with model 3, the extrapolation by in-
verse probability weighting in this model 
appears to have adjusted for the lower 
Fig. 3. Outline of the national tuberculosis prevalence survey, Gambia, 2012
100 678 total people 
enumerated in census
55 832 (55.5%) people 
eligible for study
43 100 (77.2%) participants
screened by any method
5948 (13.8%) participants eligible
for sputum collection
5523 (92.9% of 5948) participants
submitted at least one sputum specimen
5519 (99.9% of 5523) participants
with laboratory results available
77 pulmonary tuberculosis cases
identified
Ineligible for study:
41 570 (41.3%) children
3276 (3.3%) adult non-residents
Non-participants:
10,664 present, refused
2068 not present
43 100 (100%) people screened by symptoms
42 942 (99.6%) people screened by CXR
2447 people eligible by symptom
screening only
2382 people eligible by CXR screening only
1050 people eligible by both methods
5376 (97.4% of 5523) people with at least 
two sputum smears examined
5398 (97.7% of 5523) people with at
least one sputum smear examined
5434 people with at least one culture
performed
5376 (97.4% of 5519) people with two
smears and two culture results available
2 cases of nontuberculous mycobacteria 
(5.6% of all 36 smear-positive cases)
71 bacteriologically confirmed cases 6 probable cases
28 smear-positive,
culture-positive
(36.4% of 77)
43 smear-negative,
culture-positive
(55.8% of 77)
6 smear-positive,
culture-negative
(7.8% of 77)
CXR: chest X-ray.
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participation in urban areas and by males. 
This result suggests that model 3 has the 
best fit for our data. Based on model 3 the 
estimated prevalence of smear-positive tu-
berculosis was 90 per 100 000 population 
(95% CI: 53–127) and for bacteriologi-
cally confirmed tuberculosis was 212 per 
100 000 (95% CI: 152–272).
Prevalent smear-positive tubercu-
losis was 3.4-fold higher in male than 
female participants. Bacteriologically 
confirmed pulmonary tuberculosis was 
2.4-fold higher than smear-positive tu-
berculosis and 2.4-fold higher in urban 
than rural areas (Table 1). Table 2 shows 
age- and sex-associated differences in 
the burden of smear and bacteriologi-
cally confirmed tuberculosis based on 
estimates from model 3.
Adjusted prevalence
We calculated the adjusted tuberculosis 
prevalence for all ages and all forms of 
tuberculosis, with the assumptions that 
children aged < 15 years were 45.9% of 
the total population,10 and that child-
hood tuberculosis and extrapulmonary 
tuberculosis were 10.5% and 6.7% of 
all total notifications, respectively. This 
produced a national prevalence for all 
age groups and all types of tuberculosis 
of 128 per 100 000 population (95% CI: 
94–162). The updated incidence was 
175 per 100 000 population (95% CI: 
135–215) and the tuberculosis case 
notification rate was 130 per 100 000 
population. Using routine country tu-
berculosis notification data, the smear 
positive tuberculosis prevalence, in the 
population aged < 15 years, was 3 per 
100 000, the revised prevalence was 53 
per 100 000.
Performance appraisal
Comparing the estimated case detection 
rates against global tuberculosis control 
targets showed that Gambia achieved 
the 70% case detection target over the 
period 2009–2013, except for the year 
2010 (64.9%; Table 3).
Discussion
The overall prevalence of bacterio-
logically confirmed and smear-positive 
pulmonary tuberculosis in Gambia were 
3.8- and 5.5-fold lower respectively than 
previously estimated in 2011.2,3 These 
results are similar to those reported 
from Ethiopia, where the overall bur-
den of tuberculosis was much lower 
than previously thought.11 Results from 
other recently concluded surveys in 
Rwanda, Sudan and Zimbabwe, are also 
expected to report lower than expected 
prevalence.1 However, recent surveys 
carried out in other parts of Africa 
(Ghana,1 Malawi,1 Nigeria,12 the United 
Republic of Tanzania1 and Zambia13) 
Table 2. Prevalence of pulmonary tuberculosis by sex and age group per 100 000 
population aged ≥ 15 years, Gambia, 2012
Group Prevalence per 100 000 population (95% CI)a
Smear-positive cases Bacteriologically confirmed 
cases
15–34 years
Male 104 (42–166) 209 (113–305)
Female 33 (0–78) 71 (20–191)
35–54 years
Male 282 (118–445) 634 (384–885)
Female 26 (0–80) 105 (19–191)
≥ 55 years
Male 83 (0–203) 325 (108–543)
Female 227 (0–557) 330 (0–677)
CI: confidence interval.
a  Model 3: robust standard errors with missing value imputation and inverse probability weighting; 
confidence intervals were calculated with exact binomial probability theory.
Table 1. Adjusted overall estimated prevalence of pulmonary tuberculosis per 100 000 population aged ≥ 15 years, Gambia, 2012
Group Prevalence per 100 000 population (95% CI)
Smear-positive cases Bacteriologically confirmed cases
Model 1a Model 2b Model 3c Model 1a Model 2b Model 3c
Overall point 
estimate
80 (44–116) 92 (55–128) 90 (53–127) 181 (129–232) 199 (147–250) 212 (152–272)
Residence
Rural 79 (27–132) 90 (44–142) 86 (32–140) 154 (90–219) 165 (102–228) 109 (54–164)
Urban 81 (35–127) 93 (44–142) 96 (43–148) 219 (138–301) 239 (152–327) 266 (164–368)
Sex
Male 139 (82–195) 151 (88–213) 148 (88–208) 295 (208–381) 309 (221–396) 333 (233–433)
Female 40 (0–81) 40 (1–80) 41(0–83) 103 (50–155) 104 (53–156) 109 (54–164)
Age group (years)
15–34 45 (19–71) 53 (23–82) 56 (24–88) 109 (63–155) 117 (70–163) 133 (76–190)
35–54 102 (57–190) 141 (59–224) 144 (65–223) 285 (178–392) 323 (199–447) 355 (219–490)
≥ 55 146 (55–387) 187 (0–385) 159 (0–367) 331 (92–570) 364 (140–588) 329 (99–558)
CI: confidence interval.
a  Model 1: logistic regression model with robust standard errors and no missing value imputation.
b  Model 2: logistic regression model with robust standard errors and missing value imputation of non-participants as well as participants.
c  Model 3: logistic regression model with robust standard errors, with missing value imputation of participants with missing smear and/or culture results, and inverse 
probability weighting applied to all survey participants to correct for differentials in participation by age, sex and recidence.4,8
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revealed higher than expected tuber-
culosis prevalence. Many of the earlier 
estimates of tuberculosis burden were 
derived from mathematical models. 
Therefore tuberculosis burdens could 
have been over- or underestimated, as 
actual measurements now suggest. For 
Gambia, it is unclear whether earlier 
figures were exaggerated or understated 
because of the varying pattern of survey 
results across Africa. This reinforces the 
need for reliable country-level measures 
of tuberculosis burden through surveys 
such as ours.
The majority of patients with tu-
berculosis identified in our study were 
unknown to the national tuberculosis 
control programme and were not on 
treatment. While passive case detection 
has well-known limitations, our data 
expose the importance of missed diag-
nostic opportunities within the routine 
health care system. This is not surprising 
given the weaknesses of health systems 
in low-and middle-income countries. 
While it remains unclear if active 
case-finding can interrupt tuberculosis 
transmission in the community through 
early diagnosis,14 strengthening of case-
finding through re-training staff and 
interventions such as the Practical Ap-
proach to Lung Health are essential.15,16 
Given that tuberculosis prevalence sur-
veys are expensive undertakings (United 
States dollars 59 per participant in this 
survey), alternative approaches to active 
case-finding are required in resource-
poor settings. 
Tuberculosis was predominantly 
found in male participants in our study. 
The overall male-to-female ratio of 2.0:1 
among participants identified with tu-
berculosis is within the range of ratios 
reported for Africa and all tuberculosis 
high-burden countries (0.5:1–3.0:1).2 
However, this conceals the fact that 
the male-to-female ratio of 3.7:1 for 
smear-positive tuberculosis in this 
survey exceeds the figures of 1.9:1 and 
1.5:1 reported for the 22 countries with 
high-tuberculosis burden and the WHO 
African Region, respectively. In addi-
tion, the male-to-female ratio of 2.2:1 
for all participants with bacteriologically 
confirmed tuberculosis exceeds the 1.7:1 
and 1.3:1 reported for the tuberculosis 
high-burden countries and Africa. This 
sex difference was consistent across the 
survey case definitions, despite the lower 
participation by eligible males.
The majority of identified persons 
with tuberculosis were in the economi-
cally productive 15–44-year age group 
and this is an important finding for 
Gambia’s economic well-being. Our 
survey also showed that tuberculosis 
prevalence increased with age, and, 
although the estimates were less precise 
for the oldest age group, our data points 
to the need for further investigation 
of tuberculosis among elderly people 
in Gambia. While the prevalence of 
smear-positive tuberculosis did not dif-
fer significantly by rural or urban area, 
urban participants were twice as likely 
to have bacteriologically confirmed 
tuberculosis. This suggests increased 
access to routine and improved tuber-
culosis diagnostic services especially TB 
cultures, and particularly in urban areas.
The finding that less than half of 
all people with tuberculosis would 
have been identified based on smear 
microscopy results alone highlights the 
limitation of this diagnostic approach. 
Furthermore, the additional number 
of participants with smear-positive 
samples identified on the basis of a posi-
tive chest X-ray highlights the limitation 
of a diagnostic algorithm based on a 
combination of symptoms and smear 
microscopy alone. Clearly, the use of 
X-ray in diagnostic algorithms would 
increase tuberculosis case notifications 
in Gambia. Our results also demonstrate 
the added benefit of using additional 
symptom categories to complement the 
most common tuberculosis symptom of 
chronic cough. More than half of partici-
pants with identified tuberculosis were 
smear-negative and culture-positive, 
indicating that additional diagnostic 
tools, e.g. rapid diagnostics tests and/
or tuberculosis cultures, are needed for 
early diagnosis.
The clinical epidemiology of non-
tuberculous mycobacterial disease in 
most of sub-Saharan Africa and indeed 
many low and middle-income countries 
is not well described. In our survey, 
5.6% of participants with smear-positive 
samples were confirmed by culture as 
due to nontuberculous mycobacteria, 
pointing to a risk of over-diagnosis of 
pulmonary tuberculosis under program-
matic conditions and the consequent 
prescription of unnecessary tuberculo-
sis therapy. This further highlights the 
limitations of smear microscopy as the 
single diagnostic modality for national 
tuberculosis programmes in low- and 
middle-income countries.
The tuberculosis case detection rate 
was around 70% for the 5 years preced-
ing the survey. Considering the > 85% 
treatment success already achieved, the 
Gambia appears to have achieved the 
DOTS strategy targets for case detec-
tion and treatment. In addition, it has 
achieved the millennium development 
goal 6c for tuberculosis – to “have halted 
by 2015 and begun to reverse the inci-
dence of malaria and other major dis-
eases by 2015”17 – and the Stop TB Part-
nership target for halving tuberculosis 
prevalence; as tuberculosis prevalence 
has decreased from 350 per 100 000 
population in 1990 to 128 per 100 000 
in 2013.18,19 There have been substantial 
investments in tuberculosis control ef-
forts in Gambia, including expansion of 
access to diagnosis and treatment, and 
various schemes to provide support to 
patients, all complemented by advocacy, 
Table 3. Tuberculosis case detection rates in Gambia in the years 2009–2013 based on 
revised tuberculosis incidence estimates
Group Year
2009 2010 2011 2012 2013
Populationa 1 681 734 1 728 394 1 776 103 1 824 777 1 882 450
Total no. of all types of 
notified tuberculosisb
2 065 1 962 2 249 2 333 2 340
Total no. of estimated 
incident casesc
2 943 3 024 3 108 3 193 3 294
No. of notified 
cases per 100 000 
population
123 114 127 128 124
Case detection rate, % 
(95% CI)
70.2 
(68.5–71.8)
64.9 
(63.1–66.6)
72.4 
(70.7–73.9)
73.1 
(71.5–74.6)
71.0 
(69.5–72.6)
 CI: confidence interval
a  Data source: Gambia 2003 National Census, Central Statistics Department, Government of the Gambia; 
other years are estimated values.
b  Data source: routine reports from the Gambia National Tuberculosis and Leprosy Programme
c  Estimated incidence is 175 per 100 000 population.
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communication and social mobilization 
efforts. However, the contribution made 
by the expanded DOTS programme to 
improved tuberculosis case detection 
and notification is unclear. While the 
DOTS strategy is credited for increasing 
tuberculosis detection and treatment 
success and in progress towards achiev-
ing global tuberculosis control targets,20 
other authors argue that it only improves 
treatment success.21 The reduced bur-
den of tuberculosis and the progress 
made via tuberculosis control efforts in 
Gambia, support the continued deploy-
ment of existing tuberculosis control 
strategies. However, the results of this 
survey highlight some gaps that need 
attention. For example, it is important 
to elucidate the factors associated with 
relatively stable tuberculosis notification 
rates despite achievement of the case 
detection and treatment success targets 
in the DOTS strategy.
This survey had some limitations. 
There were fewer participants than the 
target sample size but this was mainly 
the result of lower participation among 
males than females. Although robust 
statistical methods were applied to 
adjust for this, we might not have com-
pletely eliminated selection bias and/or 
the possibility that this survey under-
estimated the burden of tuberculosis 
in male participants. Despite the risk 
of reported sex differences being un-
derstated and the less precise estimates 
for some of the sub-group analyses, 
we believe the results here are valid 
because the observed sex differences 
are consistent with reports from other 
surveys and the literature. In addition, 
the survey was not designed to directly 
measure extrapulmonary or childhood 
tuberculosis. Although we did not offer 
voluntary testing and counselling for hu-
man immunodeficiency virus infection, 
such counselling is offered routinely 
to all newly diagnosed tuberculosis 
patients at tuberculosis treatment sites 
in Gambia, and uptake among newly 
diagnosed persons with tuberculosis 
exceeds 75%.1,22 ■
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صخلم
2012 ماع في اهلمكأب ةلودلا ىوتسم لىع ايبماغ في لسلا ضرم راشتنا ىدم لوانتي حسم
 ناكسلا ينب طشنلا يوئرلا لسلا ضرم شيفت ىدم ريدقت ضرغلا
.ايبماغ في
 رثكأ  وأ  اًماع  15  مهرماعأ  غلبت  نيذلا  صاخشلأا  عضخ  ةقيرطلا
 ةلودلا  ىوتسم لىع لحارلما  ددعتم يدوقنع حسم في اوكراش نمم
 2013 ريانيو 2011 لولأا نوناك/برمسيد ينب ةترفلا في اهلمكأب
 مادختساب  طشنلا  يوئرلا  لسلاب  ةباصلإا  نع  فشكلل  صحفل
 .لسلا  ضارعأ  نع  فشكلل  صحفو  ةعشلأاب  ردصلا  ريوصت
 صاخشلأا نم قاصبلا نم تانيع عجم مت ،صيخشتلا نم دكأتللو
 تانيعلا  كلت  تعضخو  ،مله  ةيبايجإ  جئاتن  صحفلا  رهظأ  نيذلا
 لئاس  طسو  في  ةعارز  تايلمعلو  يرولفلا  رهجلما  تتح  صحفلل
 ميقلا  باسح ةقيرطب ةناعتسلاا تتمو .لسلا  ايتركب نع فشكلل
 ريدقت  في  سيكعلا  لماتحلاا  حيجرت  بولسأو  ةددعتلما  ةيضيوعتلا
.لسلا ضرم شيفت ىدم
 55,832  ةكراشملل  ينلهؤلما  صاخشلأا  ددع  غلب  جئاتنلا
 تغلب يتلاو مهدادعأ ءاصحإ مت نيذلا صاخشلأا ينب نم صخش
 ةبسنب(  صخش  43,100  لعفلاب  مهنم  كراش  دقو  ،100,678
 )% 99.6  ةبسنب  ؛42942(  ينكراشلما  مظعم  عضخو  .)% 77.2
 ضرلما  ضارعأ  روهظ  نع  فشكي  يذلا  صحفلل  حجان  ءارجلإ
 ددع غلبو .ةينيسلا ةعشلأاب ردصلا ريوصت لىع دمتعي يذلا كلذو
 ،)% 13.8  ةبسنب(  طقف  اًصخش  5948  قاصبلا  رابتخلا  ينلهؤلما
 لسلاب  ةباصلإل  تلااح  صاخشلأا  ءلاؤه  ينب  نم  رهظ  ثيح
 ،اًصخش  43  ىدل  ةيجولويتركبلا  قرطلاب  اهصيخشت  ديكأت  مت
 رهظأو ،اًصخش 28 ىدل ةحسلما صحفل ةيبايجلإا جئاتنلا تدكأتو
 ةباصلإل يرشت  ةحسلما  صحفل  ةلمتمح ةيبايجإ  جئاتن  صاخشأ ةتس
 )69/58( لسلاب ةباصلإا تلااح نم ديزلما ديدتح متو .ضرلماب
 فشكلا مادختساب ًةنراقم ةينيسلا ةعشلأاب ردصلا ريوصت للاخ نم
 شيفت نإف ،تاريدقتلل اًقفوو .)71/43( طقف ضارعلأا روهظ نع
 للاخ نم اهصيخشت ديكأت مت يتلا يوئرلا لسلاب ةباصلإا تلااح
 ةيجولويتركبلا  قرطلاو  قاصبلا  ةحسم  صحفل  ةيبايجلإا  جئاتنلا
 – 53 :% 95 اهرادقم ةيحجرأ ةبسنب( ةلاح 90 هرادقم ًلادعم غلب
 )272 – 152 :% 95 اهرادقم ةيحجرأ ةبسنب( ةلاح 212و )127
 لىع  ،ةمسن  100,000  اهدارفأ  ددع  غلبي  ةيناكس  ةعوممج  لك  في
 ؛333(  روكذلا  دنع  لسلا  ضرم  شيفت  ةبسن  تعفتراو  .لياوتلا
 ةعومجلما في كلذكو )433 – 233 :% 95 اهرادقم ةيحجرأ ةبسنب
 اهرادقم ةيحجرأ ةبسنب ؛355( اًماع 54  لىإ 35  نس نم ةيرمعلا
.)490–219 :% 95
 هنأ لاإ ،ايبماغ في عفترم لدعمب لسلا ضرم ءبع لظي جاتنتسلاا
 لك في ةلاح 490 دوجو لىإ تراشأ يتلا ةقباسلا تاريدقتلا نع لقي
 .2010 ماع في ةمسن 100,000 اهدارفأ ددع غلبي ةيناكس ةعوممج
 لىع اًدماتعا اهلمكأب تلاالحا نم فصنلا نع لقي ام ديدتح مت دقو
 دوهلجا بلطتتسو .هدحو قاصبلا ةحسلم يرهجلما صحفلا جئاتن
 يتلا  تلاخدتلا  ضعب  ضرلما  لىع  ةرطيسلا  في  حاجنلل  ةيمارلا
 يرفوتو ةعشلأاب ريوصتلل عوضلخا صرف ةدايزو ،لاجرلا فدهتست
.ةعيسرلاو ةقيقدلا ةيصيخشتلا تارابتخلاا نم ديزلما
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摘要
2012 年冈比亚全国范围内肺结核患病率调查
目的 旨在预测冈比亚境内活动性肺结核患病率。
方法 在 2011 年 12 月到 2013 年 1 月期间，研究人员
采用 X 线胸片对年龄为 15 岁以及上参与全国范围内、
多阶段整群调查的人员进行活动性肺结核筛查以及肺
结核症状筛查。为进行确诊，研究人员采集了筛查结
果阳性人员的痰液样本并对其进行荧光显微镜观察以
及肺结核液体培养基培养。还采用多重填补法和逆概
率加权法以估算肺结核患病率。
结果 在选出的 100,678 人中，55 ,832 人有资格参与调
查，其中 43,100 (77.2%) 人参与了调查。我们通过 X 
线胸片成功地对大部分参与者（42,942 人 ；99.6%）进
行了症状筛查。仅 5,948 (13.8%) 人有资格参加痰液检
验，结果显示 43 人为细菌学检查阳性，28 人痰涂片
检查为阳性，并且发现了六例痰涂片检查疑似阳性的
肺结核病例。相对于单纯症状查痰法 (43/71)， X 线胸
片可确诊更多肺结核病例 (58/69)。每 10 万人中，预
计痰涂片阳性和细菌学检查阳性的肺结核患病人数分
别为 90（95% 置信区间，CI: 53-127) 和 212 (95% 置信
区间，CI: 152–272)。男性 (333; 95% CI: 233–433) 以
及年龄介于 35–54 岁的人群 (355; 95% CI: 219–490) 
肺结核患病率更高 。
结论 冈 比 亚 境 内 肺 结 核 患 病 率 居 高 不 下， 但 低
于 2010 年估计的每 10 万人中 490 例的患病率。在所
有病例中，半数以下病例本可以仅仅通过显微镜观察
痰涂片确诊。为有效控制疾病发展，需要对男性采取
干预措施、进一步促进 X 线胸片以及更多精确、快速
诊断检测方法的普及。
Résumé
Enquête sur la prévalence de la tuberculose à l’échelle nationale en Gambie en 2012
Objectif Estimer la prévalence de la tuberculose pulmonaire active dans 
la population de Gambie.
Méthodes Entre décembre 2011 et janvier 2013, dans le cadre d’une 
enquête nationale en grappes à plusieurs degrés, un dépistage de la 
tuberculose pulmonaire active a été réalisé au moyen d’un questionnaire 
sur les symptômes tuberculeux et d’une radiographie pulmonaire, chez 
des personnes âgées de 15 ans ou plus ayant consenti à participer. 
Pour confirmer le diagnostic, des échantillons d’expectoration ont 
été collectés pour tous les participants dont les résultats de dépistage 
s’étaient révélés positifs, en vue de réaliser des examens par microscopie 
de fluorescence et des cultures en milieu liquide. Les techniques 
d’imputation multiple et de pondération par l’inverse de la probabilité 
ont été utilisées pour estimer la prévalence de la tuberculose.
Résultats Sur les 100 678 personnes recensées, 55 832 étaient éligibles 
pour participer à l’étude et, parmi elles, 43 100 personnes (77,2%) ont 
participé. La majorité des participants (42 942; 99,6%) ont effectivement 
répondu au questionnaire sur les symptômes et passé une radiographie 
pulmonaire. Seules 5 948 personnes (13,8%) ont été éligibles pour un 
examen des expectorations, ce qui a entraîné le dépistage de 43 cas 
de tuberculose confirmée bactériologiquement, de 28 cas formels 
de tuberculose à frottis positif et de 6 cas probables de tuberculose 
à frottis positif. Les radiographies pulmonaires ont permis d’identifier 
plus de cas de tuberculose (58/69) que le seul questionnaire sur les 
symptômes (43/71). Les prévalences de la tuberculose pulmonaire à 
frottis positif et de la tuberculose bactériologiquement confirmée ont 
respectivement été estimées à 90 cas (intervalle de confiance de 95%: 
53–127) pour 100 000 habitants et 212 cas (IC 95%: 152–272) pour 
100 000 habitants. La prévalence de la tuberculose s’est avérée plus 
élevée dans la population masculine (333 cas; IC 95%: 233–433) et dans 
la tranche des 35–54 ans (355; IC 95%: 219-490).
Conclusion La charge de la tuberculose reste élevée en Gambie, 
même si elle a baissé par rapport à la précédente estimation, réalisée 
en 2010, qui faisait état de 490 cas pour 100 000 habitants. En utilisant 
uniquement la microscopie des frottis, moins de la moitié des cas 
auraient été identifiés. Pour être efficaces, les efforts de lutte contre 
la tuberculose doivent inclure des campagnes ciblant les hommes, 
améliorer l’accessibilité des examens radiographiques et utiliser des 
tests diagnostiques rapides plus précis.
Резюме
Исследование распространенности туберкулеза в национальном масштабе — Гамбия, 2012 год
Цель Оценить популяционную распространенность активной 
формы туберкулеза легких в Гамбии.
Методы В период с декабря 2011 года по январь 2013 года 
лица в возрасте ≥ 15 лет принимали участие в национальном 
многоэтапном исследовании с применением гнездовой 
выборки; их обследовали на наличие активной формы 
туберкулеза легких при помощи рентгенографии грудной 
клетки, а также проверяли наличие у них клинических 
симптомов туберкулеза. С целью подтверждения диагноза у 
лиц, для которых результаты скринингового обследования 
были положительными, брали пробу мокроты и подвергали 
ее флуоресцентной микроскопии, а также применяли 
ее посев на жидкую питательную среду. Для оценки 
распространенности туберкулеза применялся метод 
множественного восстановления пропущенных данных и метод 
весовых коэффициентов для величин, обратных вероятности.
Результаты Из 100 678 человек, зарегистрированных для 
проведения обследования, 55 832 отвечали критериям 
исследования. Из них 43 100 человек (77,2%) приняли участие в 
исследовании. В большинстве своем участники (42 942 (99,6%)) 
успешно прошли скрининг симптомов и рентгенографию 
грудной клетки. Только 5 948 участников (13,8%) отвечали 
критериям для сдачи мокроты на анализ, из них в 43 случаях было 
получено бактериологическое подтверждение, 28 мазков были 
квалифицированы как достоверно положительные, шесть — как 
вероятные случаи туберкулеза. Рентгенография грудной клетки 
выявила больше случаев туберкулеза (58 из 69), чем диагностика 
только по симптомам (43 из 71). Оценка распространенности 
положительного мазка на туберкулез и бактериологически 
подтвержденного туберкулеза легких составила 90 (95%-й 
доверительный интервал, ДИ: 53–127) и 212 (95%-й ДИ: 152–
272) на 100 000 населения соответственно. Туберкулез чаще 
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встречался среди мужчин (333, 95%-й ДИ: 233–433) и лиц в 
возрасте 35–54 лет (355, 95%-й ДИ: 219–490).
Вывод В Гамбии сохраняется высокое бремя туберкулеза, 
но полученные оценочные значения ниже величины, 
рассчитанной в 2010 году, в 490 случаях на 100 000 населения. 
Менее половины всех случаев могли быть выявлены только 
на основании микроскопического исследования мазка. 
Для успеха контролирующих мероприятий потребуются 
вмешательства, ориентированные на мужчин, более широкий 
доступ к рентгенографии и более точные и быстродействующие 
диагностические тесты.
Resumen
Una encuesta nacional de prevalencia de la tuberculosis en Gambia, 2012
Objetivo Estimar la prevalencia de la tuberculosis pulmonar activa entre 
la población en Gambia.
Métodos Entre diciembre de 2011 y enero de 2013, personas de 15 años 
o más que participaron en una encuesta nacional en varias etapas y a 
nivel de grupos fueron examinadas en busca de tuberculosis pulmonar 
activa mediante una radiografía de tórax y para encontrar síntomas de 
tuberculosis. Para confirmar el diagnóstico, se recolectaron muestras de 
esputo de las personas cuyo examen resultó positivo y se sometieron 
a microscopia de fluorescencia y cultivos líquidos de tuberculosis. Para 
calcular la prevalencia de la tuberculosis, se utilizaron varias asignaciones 
y análisis de probabilidad inversa.
Resultados De las 100 678 personas enumeradas, 55 832 se 
consideraron aptas para participar, de las cuales 43 100 (77,2%) 
participaron. La mayoría de los participantes (42 942; 99,6%) fueron 
examinados con éxito para detectar síntomas, así como por radiografía 
del tórax. Solo 5 948 (13,8%) fueron aptos para pruebas de esputo, lo que 
dio lugar a 43 confirmados a nivel bacteriológico, 28 casos bacilíferos de 
tuberculosis definitivos y 6 casos bacilíferos de tuberculosis probable. 
Las radiografías del tórax identificaron más casos de tuberculosis 
(58/69) que los síntomas por sí solos (43/71). La prevalencia estimada 
de tuberculosis pulmonar bacilífera y confirmada a nivel bacteriológico 
fue de 90 (intervalo de confianza, IC, del 95%: 53–127) y 212 (IC del 95%: 
152–272) por cada 100 000 habitantes, respectivamente. La prevalencia 
de la tuberculosis fue mayor en hombres (333; IC del 95%: 233–433) y 
en los grupos de edad entre 35 y 54 años (355; IC del 95%: 219–490).
Conclusión Los índices de tuberculosis siguen siendo altos en 
Gambia, pero inferiores a las estimaciones anteriores de 490 por cada 
100 000 habitantes en 2010. Se identificaron menos de la mitad de 
todos los casos según los resultados de la microscopia de frotis por sí 
solos. Para que los esfuerzos de control tengan éxito, serán necesarias 
intervenciones enfocadas a los hombres, un mayor acceso a radiografías 
y pruebas de diagnóstico más rápidas y exactas.
References
1. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. 
Available from: http://www.who.int/tb/publications/global_report/en/ [cited 
2015 Nov 2].
2. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.
3. Global tuberculosis control 2010. Geneva: World Health Organization; 
2010. Available from: http://reliefweb.int/sites/reliefweb.int/files/resources/
F530290AD0279399C12577D8003E9D65-Full_Report.pdf [cited 2016 Feb 12].
4. Tuberculosis prevalence surveys: a handbook. 2nd ed. Geneva: World Health 
Organization; 2010. p. 324.
5. Stiles T, Grant V, Mawbey N. Good clinical laboratory practice (GCLP): a quality 
system for laboratories which undertake the analysis of samples from clinical trials. 
Ipswich: British Association of Research Quality Assurance; 2011.
6. NEQAS website. Sheffield: United Kingdom National External Quality Assessment 
Service; 2015. Available from: http://www.ukneqas.org.uk/content/PageServer.asp
?S=803929340&C=1252&Type=G&ID=62 [cited 2016 Apr 14].
7. Tuberculosis prevalence surveys: a handbook. Geneva: World Health 
Organization; 2011. Available from: http://www.who.int/tb/advisory_bodies/
impact_measurement_taskforce/resources_documents/thelimebook/en/ [cited 
2016 Apr 12].
8. Floyd S, Sismanidis C, Yamada N, Daniel R, Lagahid J, Mecatti F, et al. Analysis of 
tuberculosis prevalence surveys: new guidance on best-practice methods. Emerg 
Themes Epidemiol. 2013;10(1):10. doi: http://dx.doi.org/10.1186/1742-7622-10-10 
PMID: 24074436
9. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple 
imputation for missing data in epidemiological and clinical research: potential and 
pitfalls. BMJ. 2009;338 jun29 1:b2393. doi: http://dx.doi.org/10.1136/bmj.b2393 
PMID: 19564179
10. The Gambia: atlas of 2003 population and housing census. Serrekunda: 
Gambia Bureau of Statistics; 2007. Available from: https://www.researchgate.
net/publication/271528468_The_Gambia_Atlas_of_2003_Population_and_
Housing_Census [cited 2016 Apr 11].
11. Kebede AH, Alebachew Z, Tsegaye F, Lemma E, Abebe A, Agonafir M, et al. The first 
population-based national tuberculosis prevalence survey in Ethiopia, 2010–2011. 
Int J Tuberc Lung Dis. 2014 Jun;18(6):635–9. doi: http://dx.doi.org/10.5588/
ijtld.13.0417 PMID: 24903931
12. Report: first national tuberculosis prevalence survey 2012, Nigeria. Abuja: Federal 
Republic of Nigeria; 2014.
13. Kapata N, Chanda-Kapata P, Ngosa W, Metitiri M, Klinkenberg E, Kalisvaart N, 
et al. The prevalence of tuberculosis in Zambia: results from the first national 
tuberculosis prevalence survey, 2013–2014. PLoS ONE. 2016;11(1):e0146392. doi: 
http://dx.doi.org/10.1371/journal.pone.0146392 PMID: 26771588
14. Uplekar M, Creswell J, Ottmani SE, Weil D, Sahu S, Lönnroth K. Programmatic 
approaches to screening for active tuberculosis. [State of the art series. Active 
case finding/screening. Number 6 in the series]. Int J Tuberc Lung Dis. 2013 
Oct;17(10):1248–56. doi: http://dx.doi.org/10.5588/ijtld.13.0199 PMID: 24025375
15. Practical approach to lung health: manual on initiating PAL implementation 
[WHO/HTM/tuberculosis/2008410, WHO/NMH/CHP/CPM//0802]. Geneva: World 
Health Organization; 2008.
16. Ottmani S, Scherpbier R, Pio A, Chaulet P, Khaled NA, Blanc L, et al., editors. 
Practical approach to lung health (PAL). A primary health care strategy for 
integrated management of respiratory conditions in people of five years of age 
and over [WHO/HTM/tuberculosis/2005351, WHO/NMH/CHP/CPM/CRA/053]. 
Geneva: World Health Organization; 2005.
17. Global strategy and targets for tuberculosis prevention, care and control after 
2015. Geneva: World Health Organization; 2015. Available from: http://www.who.
int/tb/post2015_tbstrategy.pdf [cited 2015 Oct 30].
18. Global plan to stop tuberculosis, 2011–2015: transforming the fight towards 
elimination of tuberculosis. Geneva: Stop TB Partnership, World Health 
Organization; 2010. Available from: http://www.stoptb.org/assets/documents/
global/plan/tuberculosis_GlobalPlanToStopTB2011-2015.pdf [cited 2014 Aug 27].
19. Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M. Global 
tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol. 2012 
Jun;10(6):407–16. PMID: 22580364
20. Glaziou P, Floyd K, Korenromp EL, Sismanidis C, Bierrenbach AL, Williams BG, et al. 
Lives saved by tuberculosis control and prospects for achieving the 2015 global 
target for reducing tuberculosis mortality. Bull World Health Organ. 2011 Aug 
1;89(8):573–82. doi: http://dx.doi.org/10.2471/BLT.11.087510 PMID: 21836756
21. Obermeyer Z, Abbott-Klafter J, Murray CJ. Has the DOTS strategy improved 
case finding or treatment success? An empirical assessment. PLoS One. 2008 
03 05;3(3):e1721. doi: http://dx.doi.org/10.1371/journal.pone.0001721 PMID: 
18320042
22. Gambia: tuberculosis profile. Geneva: World Health Organization; 2012. Available 
from: http://www.who.int/tb/country/data/profiles/en/ [cited 2014 Feb 12].
